Biotech Stocks

Goldman Sachs: 3 Standout Healthcare Stocks That Could Double

The S&P 500 closed at an all time high on Monday evening — then closed at an even higher high on Wednesday — …

Agile (AGRX): Should You Catch this Falling Knife?

Shares of Agile Therapeutics (AGRX), a biotech which specializes in women’s healthcare, are in a nose dive, down about 66% in the past …

3 ‘Perfect 10’ Biotech Stocks to Buy Amid Volatile Market Environment

When it comes to stocks that can shoot up overnight, biotechs are the name of the game. This group’s extreme volatility lies in …

Morgan Stanley: 2 European Stocks to Overthrow the US Market Dominance

The last decade, since the financial crisis of 2008 and the subsequent Great Recession, have seen a heavy dominance of US companies in …

3 Top Biotech Stocks With Major Catalysts in October

Along with healthcare stocks in general, biotechnology stocks are not hitting any near-term highs in terms of share price performance. Chalk it up …

3 ‘Strong Buy’ Biotech Stocks That Could Triple in 2020

In any industry, there are always deals that are too good to be true and unfortunately, they usually are. The best thing to …

3 Biotech Stocks That Could Triple in 2020

2019 has not been a great year to own biotech stocks (so far). Since the year began, the Nasdaq Biotechnology Index (NBI) is …

3 “Strong Buy” Biotech Stocks Ahead of FDA Verdicts

Most biotech stocks have been under pressure recently, but as we approach the end of the year, many analysts are quite bullish as …

Agile (AGRX) Stock Could Be Ready to Break Out

At just $68 million in market capitalization, Agile Therapeutics (AGRX) is anything but what you’d call “Big Pharma” — but it’s getting bigger. …

Sarepta (SRPT) Stock Still Worth Over $200, Says Top Analyst

On Monday, when the FDA came out against Sarepta Therapeutics’ (SRPT) Duchenne muscular dystrophy drug Vyondys 53, investors knew the shockwaves would immediately …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts